Palace welcomes DOST study on use of blood plasma as therapy for COVID-19

in Latest News

MANILA, Philippines — Malacaang welcomed the Department of Science and Technology’s (DOST) move to start a study on using convalescent blood plasma as therapy for those sickened with coronavirus disease (COVID-19).

“The Palace welcomes the announcement of Department of Science and Technology (DOST) Secretary Fortunato T. de la Pea on the start of the government-funded study looking on the use of convalescent blood plasma as one of the modes of therapy for COVID-19,” presidential spokesman Harry Roque said in a statement.

The convalescent plasma is the liquid part of blood collected from patients who survived from the respiratory disease as they develop antibodies against the dise…

Keep on reading: Palace welcomes DOST study on use of blood plasma as therapy for COVID-19

Leave a Reply

Your email address will not be published.

*